
Probing Pyruvate Dehydrogenase E1-beta Deficiency: The Role of Genetic Testing
Explore how genetic testing aids in diagnosing pyruvate dehydrogenase E1-beta deficiency, a mitochondrial disorder affecting energy conversion and neurological function.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing aids in diagnosing pyruvate dehydrogenase E1-beta deficiency, a mitochondrial disorder affecting energy conversion and neurological function.

Developmental delays, intellectual disability and physical anomalies mark this rare disorder. Targeted gene panels or exome sequencing can confirm Rafiq Syndrome.

Missing IgA or IgE leaves the immune system short of key antibodies, leading to repeated respiratory and gut infections. IGHA1 and IGHE mutations have been linked.

Identifying the mutation behind RP60 allows monitoring to begin before symptoms appear and clarifies whether a patient qualifies for emerging gene therapies.

Autosomal dominant, autosomal recessive and X-linked patterns all occur in RP62. Knowing which mutation is present shapes counseling and monitoring.

Excess bone growth, especially in the skull, can compress nerves and raise intracranial pressure. LRP4 mutations distinguish this form from SOST-linked Sclerosteosis 1.

Thoracic insufficiency from shortened ribs is the central risk in SRTD10; DYNC2H1 variants disturb cilia, and early or prenatal testing guides management.

A novel deletion and missense variant in WDR35 have been reported in SRTD7, a skeletal disorder with shortened ribs, a narrow thorax and sometimes extra digits.